CD19 and common variable immunodeficiency: Overall, IgA spots were significantly lower in the CVID patients compared to the HCs as assessed per 10,000 CD19+ B-cells (Figure 3D), 1000 CS MBCs (Figure 3E), and 1000 CS PBs (Figure 3F).